Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Third Kind Venture Capital (3KVC) is an early-stage venture capital firm headquartered in New York City, founded by Shana Fisher in 2010. It focuses on sectors including software, digital media, financial services, life sciences, healthtech, and consumer technology. The firm typically invests during the pre-seed, seed, and Series A stages and manages a diverse portfolio with over 150 investments and more than 60 exits. 3KVC provides both capital and strategic guidance to scalable businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Third Kind Venture Capital.